The Valley Desk

ArticleAlzheimer's & dementia : the journal of the Alzheimer's AssociationPublished

The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer's disease based solely on biomarker evidence

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published
PubMed ID
40243238
PubMed Central ID
PMC12004391
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal